| Monocytes and macrophages in spondyloarthritis: functional roles and effects of current therapies S Martínez-Ramos, C Rafael-Vidal, JM Pego-Reigosa, S García Cells 11 (3), 515, 2022 | 17 | 2022 |
| Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis A Igea, T Carvalheiro, B Malvar‐Fernández, S Martinez‐Ramos, ... Arthritis & Rheumatology 74 (6), 972-983, 2022 | 14 | 2022 |
| HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients S Martínez-Ramos, C Rafael-Vidal, B Malvar-Fernández, ... Rheumatology 62 (7), 2621-2630, 2023 | 5 | 2023 |
| Semaphorin3B promotes an anti-inflammatory and pro-resolving phenotype in macrophages from rheumatoid arthritis patients in a MerTK-dependent manner S Martínez-Ramos, C Rafael-Vidal, B Malvar-Fernández, N Perez, ... Frontiers in Immunology 14, 1268144, 2024 | 1 | 2024 |
| Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner C Rafael-Vidal, S Martínez-Ramos, B Malvar-Fernández, ... Frontiers in Immunology 14, 1277267, 2023 | 1 | 2023 |
| POS0289 NOVEL ENDOTHELIAL PROGENITOR CELLS POPULATIONS AS BIOMARKERS OF DAMAGE AND REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS. S García, CR Vidal, B Malvar-Fernández, S Martínez-Ramos, IA González, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 259-260, 2024 | | 2024 |
| POS0300 SEMAPHORIN5A IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS AND REINFORCES THE MACROPHAGES EXPRESSION OF KEY PRO-INFLAMMATORY MEDIATORS JM Lobo, C Rafael-Vidal, S Martínez-Ramos, B Malvar-Fernández, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 268-269, 2024 | | 2024 |
| Expression of semaphorin‐3A in the joint and role in osteoarthritis X Li, S Martinez‐Ramos, FT Heedge, A Pitsillides, G Bou‐Gharios, ... Cell Biochemistry and Function 42 (3), e4012, 2024 | | 2024 |
| P8 Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus C Rafael-Vidal, S Martínez-Ramos, B Malvar-Fernández, ... Lupus Science & Medicine 11 (Suppl 1), 2024 | | 2024 |
| An update of murine models and their methodologies in immune-mediated joint damage and pain research S Martínez-Ramos, S García International Immunopharmacology 128, 111440, 2024 | | 2024 |
| POS1048 SEMAPHORIN3B PROMOTES A RESOLVING-INFLAMMATION PHENOTYPE IN MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS S Martínez-Ramos, CR Vidal, BM Fernández, N Perez-Gomez, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 842-842, 2023 | | 2023 |
| AB0077 SEMAPHORIN4B IS UPREGULATED IN RHEUMATOID ARTHRITIS PATIENTS AND INDUCES EXPRESSION OF INFLAMMATORY MEDIATORS BY MACROPHAGES AND FIBROBLAST-LIKE SYNOVIOCYTES S Martínez-Ramos, CR Vidal, BM Fernández, N Perez-Gomez, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1217-1217, 2023 | | 2023 |
| POS1414 TYPE I INTERFERONS INDUCE TIE2-MEDIATED ENDOTHELIAL CELL DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS CR Vidal, BM Fernández, S Martínez-Ramos, CM Rodríguez, IA González, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1061-1061, 2023 | | 2023 |
| Semaphorin3B plays a central role in serum-induced arthritis model and is reduced in patients with rheumatoid arthritis. A Igea, T Carvalheiro, B Malvar-Fernández, S Martinez-Ramos, ... Arthritis & Rheumatology (Hoboken, NJ), 2022 | | 2022 |
